公式動画ピックアップ
AAPL
ADBE
ADSK
AIG
AMGN
AMZN
BABA
BAC
BL
BOX
C
CHGG
CLDR
COKE
COUP
CRM
CROX
DDOG
DELL
DIS
DOCU
DOMO
ESTC
F
FIVN
GILD
GRUB
GS
GSK
H
HD
HON
HPE
HSBC
IBM
INST
INTC
INTU
IRBT
JCOM
JNJ
JPM
LLY
LMT
M
MA
MCD
MDB
MGM
MMM
MSFT
MSI
NCR
NEM
NEWR
NFLX
NKE
NOW
NTNX
NVDA
NYT
OKTA
ORCL
PD
PG
PLAN
PS
RHT
RNG
SAP
SBUX
SHOP
SMAR
SPLK
SQ
TDOC
TEAM
TSLA
TWOU
TWTR
TXN
UA
UAL
UL
UTX
V
VEEV
VZ
WDAY
WFC
WK
WMT
WORK
YELP
ZEN
ZM
ZS
ZUO
公式動画＆関連する動画 [アストラゼネカ AZN] （ランダムに表示）
High throughput screening at The DISC: a new era of drug discovery
astrazeneca 2025-02-13 に公開
Our global strategic R&D facility, The Discovery Centre (DISC) in Cambridge, houses one of the largest and most advanced compound management and high throughput screening ...more
Full Year and Q4 2024 Results
astrazeneca 2025-02-06 に公開
Our CEO Pascal Soriot shares our strong 2024 performance with continued double-digit growth and scientific progress across all Therapy Areas.
We're also pleased to anno ...more
Cell therapy uncovered: advancing cell therapy in the clinic
astrazeneca 2025-01-23 に公開
With our global team of experts, we are applying our deep experience and expertise to optimise the cell therapy development process. We’re investigating our diverse pipel ...more
Cell therapy uncovered: advancing armoured CAR-Ts for solid tumours
astrazeneca 2025-01-23 に公開
We’re researching ways to bring the promise of cell therapy to solid tumours, using innovative strategies to armour our CAR-Ts so they can resist the immune-suppressive t ...more
Cell therapy uncovered: pioneering TCR-Ts to target neoantigens in cancer treatment
astrazeneca 2025-01-23 に公開
We’re creating T cell receptor therapies to recognise and target cancer-associated mutations, including patient-specific neoantigens. Our T cell receptor therapies unlock ...more
Cell therapy uncovered: overcoming manufacturing hurdles
astrazeneca 2025-01-23 に公開
We’re exploring new ways to streamline and scale manufacturing for cell therapy, with the aim of enhancing T cell activity and bringing cell therapy to patients faster.
...more